| Kevin Oneal Tracey, | |
|
14375 Miramar Pkwy, Miramar, FL 33027-4134 | |
| (954) 447-9212 | |
| Not Available |
| Full Name | Kevin Oneal Tracey |
|---|---|
| Gender | Male |
| Speciality | Pharmacist |
| Location | 14375 Miramar Pkwy, Miramar, Florida |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1104567114 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 183500000X | Pharmacist | PS63017 (Florida) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Kevin Oneal Tracey, 12459 Nw 17th Ct, Pembroke Pines, FL 33028-1893 Ph: (954) 861-9164 | Kevin Oneal Tracey, 14375 Miramar Pkwy, Miramar, FL 33027-4134 Ph: (954) 447-9212 |
News Archive
Activaero GmbH, the leading company in the field of controlled breathing technologies for inhaled therapeutic agents, announced today the closing of a Series A financing totalling € 10.7 Million ($16 million). The international consortium was led by BioMedPartners AG (advising BioMedInvest LP II) and included VI Partners AG, Abalis Finance AG and Vesalius Biocapital I SICAR S.A.. The transaction was advised by MedVenture Partners GmbH.
Boston Scientific Corporation today announced that it has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) to market its WallFlex(®) Biliary RX fully and partially covered stents for the palliative treatment of malignant bile duct strictures. The WallFlex Biliary RX uncovered stent was cleared by the FDA in 2006.
Scientists from Duke-NUS Medical School have derived a structural model of a transporter at the blood-brain barrier called Mfsd2a. This is the first molecular model of this critical transporter, and could prove important for the development of therapeutic agents that need to be delivered to the brain -- across the blood-brain barrier. In future, this could help treat neurological disorders such as glioblastoma.
Baxter International Inc. today reported first quarter net income of $525 million, an increase of 2 percent from $516 million reported in the first quarter of 2009. Earnings per diluted share of $0.86 increased 4 percent from $0.83 per diluted share reported in the prior-year period. Baxter's first quarter financial results included a one-time, non-cash special charge of $39 million (or $0.07 per diluted share) related to a change in the tax treatment of post-retirement prescription drug benefits under recent U.S. healthcare reform legislation.
Haemonetics Corporation today announced that it is extending its previously announced cash tender offer, through its wholly-owned subsidiary Atlas Acquisition Corp., for all outstanding shares of common and preferred stock of Global Med Technologies, Inc., until 12:00 midnight, Boston, Massachusetts time, on Wednesday, March 24, 2010.
› Verified 8 days ago
Ms. Leslie Maria Santana, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 2900 N Commerce Pkwy, Miramar, FL 33025 Phone: 786-523-6901 | |
Farah Arias, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 2900 N Commerce Pkwy, Miramar, FL 33025 Phone: 786-362-8280 | |
Dr. Tamika L Cole, PHARMD, CPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 3125 Commerce Pkwy, Miramar, FL 33025 Phone: 954-123-4567 | |
Nelson G. Vazquez, PHARM D. Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 13218 Sw 44th St, Miramar, FL 33027 Phone: 305-829-8178 | |
Yeny Vargas, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 2900 N Commerce Pkwy, Miramar, FL 33025 Phone: 786-362-8280 | |
Dr. Katherine E Neudahl, PHARM.D. Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 2900 N Commerce Pkwy, Miramar, FL 33025 Phone: 651-202-7692 | |
Dr. Rebecca Gallo, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 11650 Miramar Pkwy, Suite 101, Miramar, FL 33025 Phone: 954-378-7900 |